Ipca Laboratories Ltd
🇰🇪Kenya
- Country
- 🇰🇪Kenya
- Ownership
- Public
- Established
- 1949-01-01
- Employees
- 22.8K
- Market Cap
- $4.2B
- Website
- http://www.ipca.com
Clinical Trials
44
Active:0
Completed:34
Trial Phases
3 Phases
Phase 1:30
Phase 3:12
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (44 trials with phase data)• Click on a phase to view related trials
Phase 1
30 (68.2%)Phase 3
12 (27.3%)Phase 4
2 (4.5%)Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
Phase 1
Completed
- Conditions
- Fasting
- Interventions
- Drug: 'TOPROL-XL®' ER Tablets 50 mg
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884857
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat,, India
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
Phase 1
Completed
- Conditions
- Fasting
- Interventions
- Drug: 'TOPROL-XL®' ER Tablets 200 mg
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884896
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
Phase 1
Completed
- Conditions
- Fed
- Interventions
- Drug: 'TOPROL-XL®' ER Tablets 200 mg
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884909
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
Phase 1
Completed
- Conditions
- Fasting
- Interventions
- Drug: GLUCOPHAGE®XR tablet 750 mg
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01831674
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Phase 1
Completed
- Conditions
- Fasting
- Interventions
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01831687
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found